Targeting the RAF/MEK/ERK PI3K/AKT and P53 pathways in hematopoietic drug resistance

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Steven L. Abrams (Creator)
Jorg Basecke (Creator)
William H. Chappell (Creator)
Camilla Evangelisti (Creator)
Richard A. Franklin (Creator)
Brian Lehmann (Creator)
Massimo Libra (Creator)
Alberto M. Martelli (Creator)
James A. McCubrey (Creator)
Linda S. Steelman (Creator)
Franca Stivala (Creator)
David M. Terrian (Creator)
Ellis WT Wong (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Additional Information

Publication
Other
Adv Enzyme Regul. 2007 ; 47: 64-103.
Language: English
Date: 2011
Keywords
hematopoietic drug resistance, acute myeloid leukemia, RAF/MEK/ERK pathway, PI3K/AKT pathway, P53 pathway

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Targeting the RAF/MEK/ERK PI3K/AKT and P53 pathways in hematopoietic drug resistancehttp://hdl.handle.net/10342/3081The described resource references, cites, or otherwise points to the related resource.